- Home
- ARQT vs LBTYK Comparison
ARQT vs LBTYK Comparison
Compare ARQT & LBTYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | LBTYK |
|---|---|---|
| Founded | 2016 | 2004 |
| Country | United States | Bermuda |
| Employees | N/A | 6636 |
| Industry | Biotechnology: Pharmaceutical Preparations | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.9B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARQT | LBTYK |
|---|---|---|
| Price | $24.19 | $11.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 1.3M |
| Earning Date | 05-05-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $34.46 | $15.41 |
| Revenue Next Year | $29.77 | $1.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $12.42 | $9.21 |
| 52 Week High | $31.77 | $13.12 |
Technical Indicators
Market Signals| Indicator | ARQT | LBTYK |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 48.82 |
| Support Level | $22.56 | $11.47 |
| Resistance Level | $25.03 | $12.20 |
| Average True Range (ATR) | 0.96 | 0.31 |
| MACD | 0.35 | -0.00 |
| Stochastic Oscillator | 77.75 | 56.98 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About LBTYK Liberty Global Ltd. Class C
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.